These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 16686544

  • 1. Carbonic anhydrase activators. Activation of isoforms I, II, IV, VA, VII, and XIV with L- and D-phenylalanine and crystallographic analysis of their adducts with isozyme II: stereospecific recognition within the active site of an enzyme and its consequences for the drug design.
    Temperini C, Scozzafava A, Vullo D, Supuran CT.
    J Med Chem; 2006 May 18; 49(10):3019-27. PubMed ID: 16686544
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Carbonic anhydrase activators: kinetic and X-ray crystallographic study for the interaction of D- and L-tryptophan with the mammalian isoforms I-XIV.
    Temperini C, Innocenti A, Scozzafava A, Supuran CT.
    Bioorg Med Chem; 2008 Sep 15; 16(18):8373-8. PubMed ID: 18774300
    [Abstract] [Full Text] [Related]

  • 5. Carbonic anhydrase activators: L-Adrenaline plugs the active site entrance of isozyme II, activating better isoforms I, IV, VA, VII, and XIV.
    Temperini C, Innocenti A, Scozzafava A, Mastrolorenzo A, Supuran CT.
    Bioorg Med Chem Lett; 2007 Feb 01; 17(3):628-35. PubMed ID: 17127057
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Designing of novel carbonic anhydrase inhibitors and activators.
    Supuran CT, Vullo D, Manole G, Casini A, Scozzafava A.
    Curr Med Chem Cardiovasc Hematol Agents; 2004 Jan 01; 2(1):49-68. PubMed ID: 15328829
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Carbonic anhydrase activators: an activation study of the human mitochondrial isoforms VA and VB with amino acids and amines.
    Vullo D, Nishimori I, Innocenti A, Scozzafava A, Supuran CT.
    Bioorg Med Chem Lett; 2007 Mar 01; 17(5):1336-40. PubMed ID: 17174092
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Designing of Novel Carbonic Anhydrase Inhibitors and Activators.
    Supuran CT, Vullo D, Manole G, Casini A, Scozzafava A.
    Curr Med Chem Cardiovasc Hematol Agents; 2004 Jan 01; 2(1):51-70. PubMed ID: 15320807
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Carbonic anhydrase inhibitors: interactions of phenols with the 12 catalytically active mammalian isoforms (CA I-XIV).
    Innocenti A, Vullo D, Scozzafava A, Supuran CT.
    Bioorg Med Chem Lett; 2008 Mar 01; 18(5):1583-7. PubMed ID: 18242985
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Carbonic anhydrase inhibitors. Zonisamide is an effective inhibitor of the cytosolic isozyme II and mitochondrial isozyme V: solution and X-ray crystallographic studies.
    De Simone G, Di Fiore A, Menchise V, Pedone C, Antel J, Casini A, Scozzafava A, Wurl M, Supuran CT.
    Bioorg Med Chem Lett; 2005 May 02; 15(9):2315-20. PubMed ID: 15837316
    [Abstract] [Full Text] [Related]

  • 20. Carbonic anhydrase inhibitors. Comparison of chlorthalidone, indapamide, trichloromethiazide, and furosemide X-ray crystal structures in adducts with isozyme II, when several water molecules make the difference.
    Temperini C, Cecchi A, Scozzafava A, Supuran CT.
    Bioorg Med Chem; 2009 Feb 01; 17(3):1214-21. PubMed ID: 19119014
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.